Our Passion, Your Health.

Press Releases & Events


22 March 2017

HYMOVIS® Demonstrates Superior Biomechanical Lubricating Properties

HYMOVIS® has exceptional lubricating properties in moving cartilage to a low-friction regime. The study provides a unifying framework to evaluate the potential clinical efficacy of injectable hyaluronic acid therapies
PARSIPPANY, NJ., March 22, 2017 - Fidia Farmaceutici S.p.A., a world leader in the research, development and manufacturing of hyaluronic acid (HA) - based products and its

7 December 2016

Gel Featuring Hyaluronic Acid Offers Long-Lasting Hydration to Women With Vaginal Dryness

FIDIA PHARMA USA INC. Introduces New Product Packaging for HYALO GYN® Featuring a Fresh, Feminine Look
PARSIPPANY, N.J., Dec. 7, 2016 – Many women suffer silently from the bothersome symptoms associated with vaginal dryness. Vaginal dryness can have many origins, including childbirth, breast-feeding, menopause, chemotherapy, oral contraceptive use and stress.1 Vaginal hydrating gels, such as HYALO


Recent Events

5 July 2016

Fidia Presents New Data on Hymovis® , a Breakthrough in Viscoelastic Technology, at the American Orthopaedic Society for Sports Medicine 2016 Annual Meeting

Hymovis® is a highly viscoelastic hydrogel (HYADD®4) engineered using a proprietary process that increases lubrication and shock absorption properties; new data demonstrating long-term benefits of Hymovis® in alleviating osteoarthritis knee pain and stiffness and improving physical function and quality of life will be presented.
PARSIPPANY, N.J., July 5, 2016 – Fidia Farmaceutici S.p.A., a world leader

Our Four Leading Principles: